Google "what are the health benefits of ketones" and you'll get dozens of hits promising everything from epilepsy control to improved heart health to more effective muscle-building at the gym. Researchers at the University of Alberta are examining the evidence to understand how ketone biology—including ketone-based therapies—may shape the management of cardiometabolic diseases including Type 2 diabetes, high blood pressure and coronary artery disease.

A phase 1 study aiming to test tolerability of combination therapy with trastuzumab deruxtecan and olaparib in Human Epidermal Growth Factor Receptor 2 (HER2)-expressing malignancies—including ovarian and uterine cancers—found a tolerable dosing schedule with promising activity, according to results reported by Dana-Farber Cancer Institute medical oncologist Dr. Elizabeth Lee at the AACR Annual Meeting 2026, held April 17–22, in San Diego, Calif.

The first sign that retired accountant Kathey Parcels had torn her left rotator cuff was pain, sudden and acute pain.

Apparently healthy cancer survivors often complain of extreme fatigue. They have finished treatment, the scans are clear, but they feel hollowed out, unable to walk to the mailbox or stay awake through dinner. The languor can linger for years, making it a major, unexplained symptom that clinicians have only been able to measure with subjective, imprecise surveys. But now a pilot study published in Biomedicines may help clinicians obtain a better measurement tool that could eventually lead to better treatments.

Variability in an individual's stuttering pattern has long posed challenges for speech-language pathologists (SLPs) when treating clients, but new research led by Charles Darwin University (CDU) and Michigan State University (MSU) has identified the gaps in clinical practices and how to address them.

Adding an extra antibiotic powder doesn't further reduce a person's risk of infection during surgery to repair complex bone fractures, a new study says. People had about the same rate of post-surgery infections whether doctors sprinkled one or two antibiotic powders into their surgical wound, researchers report in the Journal of the American Medical Association.

Researchers at the University of Eastern Finland have identified a new geometric marker of the brain ventricles that could help predict which patients with idiopathic normal pressure hydrocephalus (iNPH) will benefit from shunt surgery, according to a recent study published in Fluids and Barriers of the CNS.

For patients with advanced solid tumors harboring specific genetic alterations, the first-in-class synthetic lethal combination of WEE1 inhibitor zedoresertib plus PKMYT1 inhibitor lunresertib demonstrated promising antitumor activity and was generally well-tolerated, according to Phase I MYTHIC trial data reported by researchers at The University of Texas MD Anderson Cancer Center.

Being stuck in a bureaucratic morass is frustrating and time-consuming; known as administrative burden, this phenomenon is unfortunately a regular feature of modern life. For some, however, administrative burden is more than an annoyance; it's an obstacle to getting essential government benefits and assistance. Because the process can be so confusing, opaque, and difficult, many people end up not signing up for the help they need for themselves and their children, even though they are eligible.

A new study published in The Journal of Immunology by researchers at the Josep Carreras Leukaemia Research Institute (IJC) has uncovered a crucial biological "off switch" in diffuse large B cell lymphoma (DLBCL), the most common and one of the most aggressive forms of blood cancer. The findings reveal that a protein called HDAC7 plays a dual role: it is essential for building a healthy immune system, and when it goes missing in cancer cells, the disease becomes significantly more dangerous. Crucially, the team showed that restoring HDAC7 in cancer cells can slow or even stop tumor growth.